Kidney Cancer Clinical Trial

NSAID Use After Robotic Partial Nephrectomy

Summary

The purpose of this study is to see how effective non-steroidal anti-inflammatory drugs (NSAIDs) are at controlling pain without side effects in participants after robotic-assisted partial nephrectomy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients undergoing uncomplicated robotic assisted laparoscopic partial nephrectomy for renal mass at the University of Miami Hospital and Network Sites (Deerfield Beach, Plantation, Lennar (Coral Gables), and Kendal).
Age 18-99.
Ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria:

Allergy to NSAIDs
Myocardial infarction or unstable angina within 12 months.
Any history of coronary artery bypass graft surgery.
History or active peptic ulcer disease, gastrointestinal (GI) bleeding, GI perforation. History of bleeding disorder. Glomerular filtration rate (GFR) < 60 mL/min/1.73m2 (Modification of Diet in Renal Disease (MDRD) equation).
Taking any anti-platelet or anti-coagulation medications concurrently (e.g. warfarin, aspirin, clopidogrel, rivaroxaban etc.)
Chronic opioid use (use within 12 weeks) or history of opioid use disorder.
Solitary kidney.
Pregnancy.
Inability to give informed consent or unable to meet requirement of the study for any reason.

Study is for people with:

Kidney Cancer

Phase:

Phase 2

Estimated Enrollment:

110

Study ID:

NCT05842044

Recruitment Status:

Recruiting

Sponsor:

University of Miami

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Miami
Miami Florida, 33136, United States More Info
Mark L Gonzalgo, MD
Contact
305-243-3246
[email protected]
Mark L Gonzalgo, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Phase:

Phase 2

Estimated Enrollment:

110

Study ID:

NCT05842044

Recruitment Status:

Recruiting

Sponsor:


University of Miami

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.